137 research outputs found

    A rodent model of HIV protease inhibitor indinavir induced peripheral neuropathy

    Get PDF
    The research leading to these results is part of the EUROPAIN Collaboration, which has received support from the Innovative Medicines Initiative Joint Undertaking, under grant agreement no 115007, resources of which are composed of financial contribution from the European Union's Seventh Framework Program (FP7/2007‐2013) and EFPIA companies’ in kind contribution. We thank Pfizer for providing indinavir and gabapentin. MC received Conicyt grant (Folio 82130016),to complete this work.Peer reviewedPostprin

    Hsp12p and PAU genes are involved in ecological interactions between natural yeast strains.

    Get PDF
    The co-existence of different yeasts in a single vineyard raises the question on how they communicate and why slow growers are not competed out. Genetically modified laboratory strains of Saccharomyces cerevisiae are extensively used to investigate ecological interactions, but little is known about the genes regulating cooperation and competition in ecologically relevant settings. To understand the genetics of ecological interactions, we isolated eight yeast strains from a single vineyard and examined the fitness in single-clone strain cultures of these natural isolates in synthetic wine must simulating their natural environment. We found great differences in the fitness of the eight strains, thus we performed genome-wide analyses in order to identify the genes involved in the establishment of their co-existence in the vineyard. The results highlight the existence of an unexpected altruistic behavior, which mainly depends on a released heat-shock protein, Hsp12p. The altruistic strain also punishes close relatives non-producers by contact dependent transmission of a killer toxin, while a membrane protein (Pau5p) can provide resistance against this toxin. The reward-punishment loop created by the combined action of Hsp12p, Pau5p and killer toxin is sufficient to steer a yeast community and ensure the survival of a cooperating strain

    Acid ceramidase is upregulated in AML and represents a novel therapeutic target

    Get PDF
    There is an urgent unmet need for new therapeutics in acute myeloid leukemia (AML) as standard therapy has not changed in the past three decades and outcome remains poor for most patients. Sphingolipid dysregulation through decreased ceramide levels and elevated sphingosine 1-phosphate (S1P) promotes cancer cell growth and survival. Acid ceramidase (AC) catalyzes ceramide breakdown to sphingosine, the precursor for S1P. We report for the first time that AC is required for AML blast survival. Transcriptome analysis and enzymatic assay show that primary AML cells have high levels of AC expression and activity. Treatment of patient samples and cell lines with AC inhibitor LCL204 reduced viability and induced apoptosis. AC overexpression increased the expression of anti-apoptotic Mcl-1, significantly increased S1P and decreased ceramide. Conversely, LCL204 induced ceramide accumulation and decreased Mcl-1 through post-translational mechanisms. LCL204 treatment significantly increased overall survival of C57BL/6 mice engrafted with leukemic C1498 cells and significantly decreased leukemic burden in NSG mice engrafted with primary human AML cells. Collectively, these studies demonstrate that AC plays a critical role in AML survival through regulation of both sphingolipid levels and Mcl-1. We propose that AC warrants further exploration as a novel therapeutic target in AML
    • 

    corecore